Cash And Cash Equivalents, Restricted Cash And Short-term Investments (Tables)

12 Months Ended

Dec. 31, 2024

Cash and Cash Equivalents [Abstract]

Schedule of Cash and Cash Equivalents

The following table disaggregates the Company's cash, cash equivalents and restricted cash, which reconciles to the total shown on the Consolidated Statements of Cash Flows:

	December 31,
	2024		2023
Cash and Cash Equivalents	$	408,240	$	199,371
Restricted Cash - Current(1)	39,302		43,897
Cash and Cash Equivalents and Restricted Cash	$	447,542	$	243,268

(1) Restricted Cash - Current is included in Other Current Assets in the accompanying Consolidated Balance Sheets.

Restrictions on Cash and Cash Equivalents

The following table disaggregates the Company's cash, cash equivalents and restricted cash, which reconciles to the total shown on the Consolidated Statements of Cash Flows:

	December 31,
	2024		2023
Cash and Cash Equivalents	$	408,240	$	199,371
Restricted Cash - Current(1)	39,302		43,897
Cash and Cash Equivalents and Restricted Cash	$	447,542	$	243,268

(1) Restricted Cash - Current is included in Other Current Assets in the accompanying Consolidated Balance Sheets.

Schedule Of Debt Securities, Available-for-Sale

The Company's investments in available-for-sale securities are as follows:

	December 31, 2024
					Gross Unrealized
	Amortized Cost		Allowance for Credit Losses		Gains		Losses		Fair Value
U.S. Treasury Securities	$	51,885	$	—	$	120	$	(12)	$	51,993

	December 31, 2023
					Gross Unrealized
	Amortized Cost		Allowance for Credit Losses		Gains		Losses		Fair Value
U.S. Treasury Securities	$	81,829	$	—	$	103	$	—	$	81,932

The Company’s investments in available-for-sale securities are as follows:

	December 31, 2024
					Gross Unrealized
	Amortized Cost		Allowance for Credit Losses		Gains		Losses		Fair Value
Global WTTF Securities	$	12,112	$	—	$	87	$	(145)	$	12,054